- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AHIP CEO Karen Ignagni Resigning for EmblemHealth Position
Karen Ignagni is stepping down as president and chief executive officer of America's Health Insurance Plans for a position with EmblemHealth in New York.
Karen Ignagni is stepping down as president and chief executive officer of America’s Health Insurance Plans (AHIP) for a position with EmblemHealth in New York.
Ms Ignagni led the American Association of Health Plans from 1993 until 2003 when it merged with the Health Insurance Association of America to form AHIP. She has not made a formal statement yet regarding her departure from AHIP, but it is being reported by POLITICO that she will replace EmblemHealth's Frank Branchini on September 1.
The AHIP Board of Directors announced that Dan Durham, executive vice president for strategic initiatives at AHIP, will serve as interim CEO as the board searches for Ms Ignagni's successor. Mr Durham has 30 years of leadership experience, primarly in the healthcare field. Before joining AHIP, he was vice president for policy at the Pharmaceutical Research and Manufacturers of America, and served in high-level positions at HHS, the Social Security Administration, and the Office of Management and Budget.
"As the health insurance industry’s top representative in Washington, Karen has successfully navigated intense challenges from the Patient’s Bill of Rights to the Affordable Care Act," wrote Mark B. Ganz, AHIP board chairman and CEO and president of Cambia Health Solutions, wrote in a statement. "With tenacity, intellect and deep policy knowledge, she ensured our industry has a seat at all tables. Perhaps her greatest contributions have been highlighting the value and innovations of this industry."
Ms Ignagni wrote one of the special guest commentary for The American Journal of Managed Care's 20th anniversary, which can be seen here, and in a separate video interview, she spoke about the influence AJMC has had on managed care in the last 2 decades. In it, she writes that health plans are at the center of innovations that are powering the evolution of patient-centered care.
"As we look toward the future, the focus of health plans will be to continue providing innovative solutions that promote affordability, access, and value for patients—that is our commitment to consumers, employers, and our public sector partners," she wrote.
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
For Neuromuscular Disease Community, an Era of Opportunities and Threats
March 17th 2025Robert Califf, MD, former commissioner of the FDA, delivered a keynote address at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference that highlighted the enormous opportunities for progress in neuromuscular disease care amid a changing policy environment.
Read More
The Impact of Cost Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More
Oz Confirmation Hearing Probes Vision for Medicaid but Coalesces Around Well-Being
March 14th 2025Mehmet Oz, MD, the nominee to lead CMS under the Trump administration, testified in a confirmation hearing before the Senate Finance Committee, where he found common ground on improving outcomes through healthier lifestyle choices but encountered repeated questions on potential Medicaid cuts.
Read More
